4//SEC Filing
Thorell Marella 4
Accession 0001694665-23-000044
CIK 0001694665other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:09 PM ET
Size
7.0 KB
Accession
0001694665-23-000044
Insider Transaction Report
Form 4
Thorell Marella
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-07+130,000→ 130,000 total - Exercise/Conversion
Restricted Stock Units
2023-05-07−130,000→ 390,000 total→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. These RSUs have no expiration date.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001826323
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:09 PM ET
- Size
- 7.0 KB